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Table 1
Incidence of Viral Infections
Virus n (%)
Pre-Mask
(n¼920)
Post-Mask
(n¼454) P-value
Any 10.3% (95) 3.3% (15) <0.0001
Inﬂuenza A 0.5% (5) 0.4% (2) 1.0*
*
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Background: Hematopoietic stem cell transplantation (HCT)
is a procedure that can inﬂict signiﬁcant physical and
emotional stress on patients. In particular, the emotional
stress may often lead to severe psychiatric debility, which
may affect nutrition and physical activity, and may lead to
lack of compliance with follow up andmedications for GVHD
and infection prophylaxis. At a minimum FACT requires “the
Clinical Program shall have access to certiﬁed or trained
consulting specialists and/or specialist groups from key
disciplines who are capable of assisting in the management
of patients requiring medical care, including but not limited
to Psychiatry. ” Currently our patients may sometimes be
evaluated by social work but there is no required psychiatric
referral. Referrals/consults are often made if psychiatric
issues develop. We wanted to determine what the practice is
at other transplant centers. Via QA analysis, our program
investigated whether we should institute a requirement for
a preBMT psychiatric consultation.
Methods: NMDP lists 154 programs on its website. 13
programs are non-NMDP programs. Programs were emailed
asking if the program required patients see a psychiatrist for
evaluation prior to transplant and to reply either “Yes” or
“No”. Not every program had email information provided.
Some were called.
Results: Responses were obtained for 89 of 154 total
programs and 2 of 13 non-NMDP programs. 27 NMDP
programs require a psychiatrist/ologist to see patients prior
to transplant. 7 such programs are for children. 19 NMDP
programs indicate they do not require a psychiatric evalua-
tion. 19 NMDP programs indicate patients are seen by social
work who then determines if a psychiatric evaluation is
needed (gatekeeper). 12 NMDP programs indicate that
patients are seen by social work but did not indicate whether
social work was a ”gatekeeper.” 2 NMDP programs attemp-
ted pre-BMT visits with psychiatry/ology but without
requirement. 6 programs indicate psychologic support for
patients who need intervention or insurance required. 2
programs indicate social work or psychiatry evaluate
patients. 2 of 13 programs listed as non-NMDP programs
responded. 2 NMDP programs said they were looking into
mandatory pre-BMT psychiatric evaluations.
Conclusion: A high proportion of programs require pre-BMT
psychiatric evaluations. Stress from transplant and resultant
psychiatric manifestations may lead to poor patient
compliance for follow up, failure to take medications prop-
erly, and, rarely, substance abuse. What do other programs
do and require? To increase the yield of responses we made
this a simple “yes” or “no” questionnaire yet additional
information was usually offered. Many programs declared
their interest in the results of this survey. We will follow up
with programs that did require a psychiatric evaluation
preBMT to determine if this hasmade a qualitative difference
in patient care.Inﬂuenza B 0.1% (1) 0% (0) 1.0
Parainﬂuenza 1 0.1% (1) 0% (0) 1.0*
Parainﬂuenza 2 0.3% (3) 0% (0) 1.0*
Parainﬂuenza 3 8.2% (75) 2.0% (9) <0.0001*
Adenovirus 0% (0) 0.4% (2) 1.0*
Respiratory Syncytial
Virus
1.7% (16) 0.4% (2) 0.24*
* One-sided Fisher’s Exact Test adjusted for multiple comparisons using
the Bonferroni approach321
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Respiratory viral infections (RVI) are frequent complications
of hematopoietic stem cell transplantation (HSCT). Para-
inﬂuenza virus 3 (PIV3) in particular affects patients after
HSCT, spreads nosocomially, and is associated with increased
morbidity and mortality. Given the absence of proven
effective treatments, prevention is key. Requiring all indi-
viduals with direct patient contact to wear a surgical mask is
a simple and inexpensive intervention that may reduce
droplet exposure by asymptomatic shedders and limit
nosocomial spread.
We performed a prospective study to assess the impact of
surgical masks. Between January 10, 2010-January 9, 2012
(mask period), all individuals with direct patient contact,
including caregivers, visitors, and medical staff, were
required to wear a surgical mask when within 3 feet of
a patient, regardless of suspicion of RVI. This continued until
the patient returned home after HSCT. The primary endpoint
was the incidence of RVI compared to the control period of
December 1, 2003-November 30, 2009 (pre-mask period). A
brief washout period (December 1, 2009-January 9, 2010)
allowed for implementation. Standard infection prevention
precautions were in place throughout both periods.
Secondary endpoints include clusters of RVI, deﬁned as 3 or
more infections in a 30-day period, and death from RVI. The
study was designed to detect a 40% reduction in the inci-
dence of RVI with 90% power.
During the six-year pre-mask period, 920 patients received
HSCTs. During the two-year mask period, 454 patients
received HSCTs. In the pre-mask and mask groups, median
age was 50 and 54 (P < .0001) (ranges 19 to 79 and 19 to 81).
With the exception of non-Hodgkin lymphoma (21% and
15%) and plasma cell dyscrasia (32% and 46%) (P ¼ .004),
there were no differences in disease representation. Alloge-
neic HSCT constituted 41% and 33% of transplants (P ¼ .004).
Median days at risk were 25 and 20 days (P ¼ .054).
The incidence of any RVI was 10.3% in the pre-mask period
and 3.3% in the mask period (P < .0001) (Table 1). Among
patients who had an allogeneic HSCT, the incidence was
16.9% and 6.7% (P ¼ .001); among patients who had an
autologous HSCT, the incidence was 5.7% and 1.6% (P ¼ .005).
Surgical mask usage had the most pronounced affect on
reducing the incidence of PIV3 (8.1% to 2.1%, P < .0001),
which was the most common virus (74% and 60% of infec-
tions), followed by RSV (16% and 13%). There were more
clusters in the pre-mask period (1.7/year vs. 0.5/year). In
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in 1.2% of patients in the pre-mask period and 0.2% in the
mask period (P ¼ .12). Patients with RVI required more peri-
transplant care (median 76 days vs. 21 days, P< .0001). These
data suggest that requiring all individuals with direct patient
contact to wear a surgical mask can reduce the incidence of
RVI, particularly PIV3, during the vulnerable period following
HSCT.322
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Objective: Previous studies suggest that edentulous
(subjects without teeth) have a lower inﬂammatory state
than non-edentulous individuals probably due to peri-
odontal infection in non-edetulous subjects. We hypothe-
sized that edentulous patients would have a lower incidence
of bacteremia and other complications associated with
autotransplantation for multiple myeloma (MM).
Methods: We conducted a retrospective case-control study
of patients who received autologous hematopoietic stem cell
transplantation (AHSCT) for multiple MM at the Audie L.
Murphy Memorial Veterans Hospital Bone Marrow Trans-
plant Unit, in San Antonio, Texas from January 2003 through
September 2012. Case subjects were deﬁned as edentulous
and controls were deﬁned as non-edentulous. The 2 groups
were matched for age, gender, ethnicity, MM stage, time
from diagnosis to transplant, performance status, and
conditioning regimen. The following posttransplant toxic-
ities were analyzed: bacteremia, oral mucositis, nausea/
vomiting, diarrhea, neutrophil engraftment and length of
hospital stay.Table 1
Post-AHSCT patient toxicities
Edentulous
N¼45
Control Group
N¼90
P-value
Bacteremia, n (%) 0.553
Yes 11 (24) 18 (20)
No 34 (76) 72 (80)
Oral mucositis, n (%) 0.465
Grade 0 13 (29) 33 (37)
Grade 1 16 (36) 21 (23)
Grade 2 13 (29) 27 (30)
Grade 3 3 (7) 9 (10)
Nausea/Vomiting, n (%) 0.744
Grade 0 4 (9) 7 (8)
Grade 1 24 (53) 40 (44)
Grade 2 14 (31) 36 (40)
Grade 3 3 (7) 7 (8)
Diarrhea, n (%) 0.095
Grade 0 6 (13) 10 (11)
Grade 1 7 (16) 17 (19)
Grade 2 15 (33) 24 (27)
Grade 3 14 (31) 39 (43)
Grade 4 3 (7) 0 (0)
Days to ANC engraftment 0.966
Mean (SD) 10.84 (1.80) 10.83 (1.16)
Range 8-31 9-17
Length of hospital stay
(days)
0.098
Mean (SD) 15.76 (4.94) 17.47 (5.99)
Range 3-30 3-52Results: During the study period, 297 AHSCT were per-
formed at our institution. Of these, 45 (15%) patients were
found to be edentulous at the time of ﬁrst AHSCT. Forty-
ﬁve case subjects were matched to 90 controls. All
patients were males, their median age was 60 years
(range, 42-75), their Karnofsky performance status score
mean was 90 (range, 70-90), and all received melphalan as
part of the conditioning regimen. The majority of patients,
90 (67%) had stage III MM at transplantation and the
median time from diagnosis to transplantation was 12
months (range, 4-103).
The incidence and severity of all posttransplant toxicities
analyzed were similar in both groups (see Table 1). Thirty-
eight (84%) of edentulous patients were smokers or had
a history of smoking at the time of AHSCT compared to 58
(64%) of the control group (P ¼ .016). Overall survival after
transplant was similar in both groups.
Conclusions: The incidence of toxicities after AHSCT
experienced by edentulous MM patients was similar to
controls including bacteremia and oral mucositis. There
was a strong association between edentulism and
smoking.323
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Microbiologically conﬁrmed infections (MCI) which occur
during stem cell transplantation (HSCT) increase morbidity
andmortality. HSCT recipients who develop polymicrobial or
multiple microbiologically conﬁrmed infections (MMCI) may
be at increased risk for unfavorable outcomes, yet data is
limited. Herein we report the incidence, risk factors and
survival associated for polymicrobial and multiple microbi-
ologically conﬁrmed infections (MMCI) in 901 HSCT
recipients.
Electronic databases were used for HSCT recipients treated at
Northwestern Memorial Hospital between 2004-09. Infec-
tion data was recorded from the time of admission through
discharge. Any single CONS or VRE BAL culture was excluded
from analysis. Patients received acyclovir, azole antifungal,
and ﬂouroquinolone for prophylaxis. Polymicrobial infection
was deﬁned as the occurrence of 2 MCI's from different
organisms within 72 hours of the 1st positive culture.
Fischers Exact test and Chi-Square was used for analysis of
continuous and discreet variables. This study is IRB
approved.
Amongst 905 HSCT recipients, 59 patients (6.8%) developed
MMCI's. Polymicrobial infection was identiﬁed in 30 (3.4%)
patients. 17 patients had > 2MCI's. Most MCI's (55%) were
blood stream infections. The duration of time which tran-
spired between positive cultures was as follows: Con-
commitant cultures (n¼13), <24 hr (n¼9), 48 hr (n¼8), <72
hr (n¼5), <96 hr (n¼4), <120 hr (n¼3), <144hr (n¼5), >7
days(n¼12). When MMCI'S cases were compared to patients
without any positive cultures using bivariate analysis,
statistically signiﬁcant differences included : female gender
(0.0377), diagnosis of myeloma (P < .0133) or AML (P <
.0497), receipt of allo-HSCT (P < .0001), vancomycin (P <
.0004)or cefepime(P < .0005) use, and positive VRE
